Exciting & important new study from my lab. Have you ever wondered how strong that alleged connection is between psychedelic use and
#Schizophrenia? This project aims to point the telescope there & give it a focused look. Please share widely. @AlexaM_Molinaro
1/🚀New research on psychedelics, context & brain connectivity!
We analysed the largest psychedelic neuroimaging dataset to date (N=62, fMRI+EEG).
Key finding: Psilocybin aligns brain activity with context, linking neural dynamics to perception.
A thread 🧵👇
Colorado is set to open its first healing centers for psychedelic mushrooms, offering supervised psilocybin therapy for mental health. With sliding-scale options and a growing focus on research, this could change the future of treatment. https://t.co/C0TAxy6hki
Delighted to announce that Cobweb of Trips: A Literary History of Psychedelics by Robert Dickins is out today! 🥳❤️📖
➡️ https://t.co/DL1ha9pPKh
Ltd Hardback & Paperback + eBook available through Amazon
Excited to share our latest publication:
'Development of a Digital Intervention for Psychedelic Preparedness (DIPP)'
https://t.co/3583eoDQxa
@SciReports@MatthewSacchet@sunjeevk
Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study
https://t.co/3as9Wdev2A
In my latest article for Psychedelic Support, I look at the most common difficulties people face after using psychedelics, based on research by @JulesEvans11 @laughteroftime @shayamsuseelan@rosmcalpine@drdluke. https://t.co/SroP27Wnzx
If anyone would like to take part in a short survey (5-10 minute) about psychedelics please let me know or click the link below for more info. This survey aims to understand current public perceptions towards the use of psychedelic substances.
https://t.co/DtxWuIxvkM
1/ How does being on #antidepressants (specifically SRIs) affect the #psychedelic experience? 💊🍄
In our new paper, Jessica Barbut and I found that those NOT on #SRIs had more intense experiences than those on SRIs. However, before/after changes in well-being and depression were comparable. With @DavidErritzoe@RCarhartHarris@ProfDavidNutt .
Below a detailed breakdown: https://t.co/BWMwmruZcB
For my money, @RCarhartHarris is simply the world's leading scholar on the science of psychedelics. This conversation digs deep into his background as a thinker and explores the implications of his most recent theoretical work: https://t.co/1VdWjWVX0L
We are deeply saddened today over the passing of our friend and colleague, Roland Griffiths. He was a remarkably courageous, kind and spirited human being. He will be sorely missed, and we are eternally grateful for everything his life represented.
Our heart goes out to all the folks who were lucky enough to know Dr. Roland Griffiths.
While it’s a sad day for all, we know he’s resting peacefully.
His legacy will live on and he will be remembered by all for his passion, kindness, curiosity, and positive attitude.
Excited to share my new research on psychedelic literacies and narrative medicine at The Hong Kong Anthropologicical Society, Fri 13th Oct, 7pm, TST, HK. Come along if you can!
My student is looking for responses to this survey. We're looking for those who have never used illicit drugs, those who have and never used psychedelics and those who have used psychedelics...everyone really! See the below link and please share :)
https://t.co/DcvNy43z2g
atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants
atai's DMT candidate was "well-tolerated with a favorable safety profile".
The company will test a "further optimized" version before initiating a Phase 2 study.
https://t.co/pNXehlB1t4
Magic mushroom retreat centers can offer healing — but their lack of regulation can carry risks
"Psychedelic retreats are becoming more popular as people wait for FDA approval. But do they work?"
https://t.co/0MEAud7j1Q